A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC

Inclusion Criteria: * Any gender,18 to 70 years old; * Preoperative diagnosis of recurrent HCC clear,liver resection was done previously; * No active hepatitis and decompensated cirrhosis; * Patient with previous liver resection, maximum diameter ≤5cm single recurrent nodules or 3 nodules in diameter and no more than 3cm,did not infringe the portal vein,hepatic vein and inferior vena cava invasion,lymph node or extrahepatic turn; * No tumor rupture or bleeding; * Child-Pugh class A or B grade,ICG-R15 \<20%; * No coagulation disorders,platelet count \> 50 × 109 / L and prolonged prothrombin time \< 5 seconds; * After diagnosis of recurrent HCC,not be including related surgery,radiofrequency ablation (RFA),TACE treatment,no certainty anticancer chemotherapy treatment;supreme absolute contraindications abdominal surgery; * Recurrent nodules are not close to intestines,stomach,cholecyst or diaphragm muscle, not close to the first porta hepatis,main vessel and biliary ducts; * Patients generally available,heart and lung function can tolerate surgery, abdominal surgery supreme absolute contraindications; * Voluntarily participate in the study, voluntarily accept any therapy of two,informed consent. Exclusion Criteria: * Opposite of the above inclusion criteria; * Severe upper abdominal adhesions; * Postoperative pathological examination of the bile duct cell or mixed cell carcinoma and pathologically confirmed positive margin; * Foreign,Hong Kong,Macao,Taiwan and other regions,estimated postoperative difficult to track,followed up; * Nodules proved to be not recurrent HCC during intraoperative exploration, such as:liver metastases of colorectal cancer.